Profile picture

Doctor Mariana Tinoco

Alto Ave Hospital Center, Guimaraes (Portugal)
Follow
Logo ESC

Contributor content

The effects of Sacubitril-Valsartan on ICD indication in patients with heart failure with reduced ejection fraction.
Presentation
The effects of Sacubitril-Valsartan on ICD indication in patients with heart failure with reduced ejection fraction.
Read more
Left ventricular reverse remodelling and prognosis of patients treated with SGLT2 inhibitors for heart failure with reduced ejection fraction.
Presentation
Left ventricular reverse remodelling and prognosis of patients treated with SGLT2 inhibitors for heart failure with reduced ejection fraction.
Read more
A single center study of patients who suffered cardiac arrest with a presumed diagnosis of acute coronary syndrome.
Presentation
A single center study of patients who suffered cardiac arrest with a presumed diagnosis of acute coronary syndrome.
Read more
Sacubitril-Valsartan versus ACEI in left ventricular reverse remodelling and in cardiovascular outcomes.
Presentation
Sacubitril-Valsartan versus ACEI in left ventricular reverse remodelling and in cardiovascular outcomes.
Read more
Impact of SGLT2 inhibitors on cardiovascular outcomes in patients with heart failure with reduced ejection fraction.
Presentation
Impact of SGLT2 inhibitors on cardiovascular outcomes in patients with heart failure with reduced ejection fraction.
Read more
Predictors of Sacubitril-Valsartan target dose achievement in a real-world population.
Presentation
Predictors of Sacubitril-Valsartan target dose achievement in a real-world population.
Read more
Safety and effectiveness of Sacubitril-Valsartan in a real-world population.
Presentation
Safety and effectiveness of Sacubitril-Valsartan in a real-world population.
Read more
Left ventricular diastolic function in patients with breast cancer under chemotherapy
Presentation
Left ventricular diastolic function in patients with breast cancer under chemotherapy
Read more
Comparison of major adverse cardiovascular events between sacubitril-valsartan versus ACEI/ARB therapy in patients with heart failure with reduced ejection fraction
Presentation
Comparison of major adverse cardiovascular events between sacubitril-valsartan versus ACEI/ARB therapy in patients with heart failure with reduced ejection fraction
Read more
Predictors of major adverse cardiovascular events in patients with heart failure with reduced ejection fraction
Presentation
Predictors of major adverse cardiovascular events in patients with heart failure with reduced ejection fraction
Read more

ESC 365 is supported by

novartis Explore sponsored resources